PeptideDB

AZD-CO-Ph-PEG4-Ph-CO-AZD 2569143-72-0

AZD-CO-Ph-PEG4-Ph-CO-AZD 2569143-72-0

CAS No.: 2569143-72-0

AZD-CO-Ph-PEG4-Ph-CO-AZD is a bis-β-lactam linker that can be used for antibody-siRNA conjugation synthesis.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

AZD-CO-Ph-PEG4-Ph-CO-AZD is a bis-β-lactam linker that can be used for antibody-siRNA conjugation synthesis.

Physicochemical Properties


Molecular Weight 496.51
Exact Mass 496.184
CAS # 2569143-72-0
PubChem CID 155422058
Appearance White to off-white solid powder
LogP 1.2
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 13
Heavy Atom Count 36
Complexity 710
Defined Atom Stereocenter Count 0
InChi Key UTXXKKZMYZBDCT-UHFFFAOYSA-N
InChi Code

InChI=1S/C26H28N2O8/c29-23-9-11-27(23)25(31)19-1-5-21(6-2-19)35-17-15-33-13-14-34-16-18-36-22-7-3-20(4-8-22)26(32)28-12-10-24(28)30/h1-8H,9-18H2
Chemical Name

1-[4-[2-[2-[2-[4-(2-oxoazetidine-1-carbonyl)phenoxy]ethoxy]ethoxy]ethoxy]benzoyl]azetidin-2-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Generation and validation of structurally defined antibody-siRNA conjugates. Nucleic Acids Res. 2020 Jun 4;48(10):5281-5293.


Solubility Data


Solubility (In Vitro) DMSO: 50 mg/mL (100.70 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.04 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0141 mL 10.0703 mL 20.1406 mL
5 mM 0.4028 mL 2.0141 mL 4.0281 mL
10 mM 0.2014 mL 1.0070 mL 2.0141 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.